1 Market Overview

1.1 Tuberculosis Prevention and Treatment Vaccine Introduction

1.2 Market Analysis by Type

1.2.1 Overview: Global Tuberculosis Prevention and Treatment Vaccine Revenue by Type: 2019 Versus 2021 Versus 2026

1.2.2 Immune Vaccine

1.2.3 Therapy Vaccine

1.3 Market Analysis by Application

1.3.1 Overview: Global Tuberculosis Prevention and Treatment Vaccine Revenue by Application: 2019 Versus 2021 Versus 2026

1.3.2 Self-Procurement

1.3.3 UNICEF

1.3.4 Other

1.4 Global Tuberculosis Prevention and Treatment Vaccine Market Size & Forecast

1.4.1 Global Tuberculosis Prevention and Treatment Vaccine Sales in Value (2016-2026))

1.4.2 Global Tuberculosis Prevention and Treatment Vaccine Sales in Volume (2016-2026)

1.4.3 Global Tuberculosis Prevention and Treatment Vaccine Price by Type (2016-2026) & (US$/Unit)

1.5 Global Tuberculosis Prevention and Treatment Vaccine Production Capacity Analysis

1.5.1 Global Tuberculosis Prevention and Treatment Vaccine Total Production Capacity (2016-2026)

1.5.2 Global Tuberculosis Prevention and Treatment Vaccine Production Capacity by Geographic Region

1.6 Market Drivers, Restraints and Trends

1.6.1 Tuberculosis Prevention and Treatment Vaccine Market Drivers

1.6.2 Tuberculosis Prevention and Treatment Vaccine Market Restraints

1.6.3 Tuberculosis Prevention and Treatment Vaccine Trends Analysis

2 Manufacturers Profiles

2.1 Merck

2.1.1 Merck Details

2.1.2 Merck Major Business

2.1.3 Merck Tuberculosis Prevention and Treatment Vaccine Product and Services

2.1.4 Merck Tuberculosis Prevention and Treatment Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.2 Japan BCG Lab

2.2.1 Japan BCG Lab Details

2.2.2 Japan BCG Lab Major Business

2.2.3 Japan BCG Lab Tuberculosis Prevention and Treatment Vaccine Product and Services

2.2.4 Japan BCG Lab Tuberculosis Prevention and Treatment Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.3 Serum Institute of India

2.3.1 Serum Institute of India Details

2.3.2 Serum Institute of India Major Business

2.3.3 Serum Institute of India Tuberculosis Prevention and Treatment Vaccine Product and Services

2.3.4 Serum Institute of India Tuberculosis Prevention and Treatment Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.4 AJ Vaccines

2.4.1 AJ Vaccines Details

2.4.2 AJ Vaccines Major Business

2.4.3 AJ Vaccines Tuberculosis Prevention and Treatment Vaccine Product and Services

2.4.4 AJ Vaccines Tuberculosis Prevention and Treatment Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.5 BioFarma

2.5.1 BioFarma Details

2.5.2 BioFarma Major Business

2.5.3 BioFarma Tuberculosis Prevention and Treatment Vaccine Product and Services

2.5.4 BioFarma Tuberculosis Prevention and Treatment Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.6 GreenSignal Bio Pharma

2.6.1 GreenSignal Bio Pharma Details

2.6.2 GreenSignal Bio Pharma Major Business

2.6.3 GreenSignal Bio Pharma Tuberculosis Prevention and Treatment Vaccine Product and Services

2.6.4 GreenSignal Bio Pharma Tuberculosis Prevention and Treatment Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.7 China National Biotec

2.7.1 China National Biotec Details

2.7.2 China National Biotec Major Business

2.7.3 China National Biotec Tuberculosis Prevention and Treatment Vaccine Product and Services

2.7.4 China National Biotec Tuberculosis Prevention and Treatment Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.8 Biomed Lublin

2.8.1 Biomed Lublin Details

2.8.2 Biomed Lublin Major Business

2.8.3 Biomed Lublin Tuberculosis Prevention and Treatment Vaccine Product and Services

2.8.4 Biomed Lublin Tuberculosis Prevention and Treatment Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.9 Taj Pharmaceuticals

2.9.1 Taj Pharmaceuticals Details

2.9.2 Taj Pharmaceuticals Major Business

2.9.3 Taj Pharmaceuticals Tuberculosis Prevention and Treatment Vaccine Product and Services

2.9.4 Taj Pharmaceuticals Tuberculosis Prevention and Treatment Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.10 Ataulpho de Paiva

2.10.1 Ataulpho de Paiva Details

2.10.2 Ataulpho de Paiva Major Business

2.10.3 Ataulpho de Paiva Tuberculosis Prevention and Treatment Vaccine Product and Services

2.10.4 Ataulpho de Paiva Tuberculosis Prevention and Treatment Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.11 IVAC

2.11.1 IVAC Details

2.11.2 IVAC Major Business

2.11.3 IVAC Tuberculosis Prevention and Treatment Vaccine Product and Services

2.11.4 IVAC Tuberculosis Prevention and Treatment Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.12 Queen Saovabha Mem. Inst

2.12.1 Queen Saovabha Mem. Inst Details

2.12.2 Queen Saovabha Mem. Inst Major Business

2.12.3 Queen Saovabha Mem. Inst Tuberculosis Prevention and Treatment Vaccine Product and Services

2.12.4 Queen Saovabha Mem. Inst Tuberculosis Prevention and Treatment Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.13 Microgen

2.13.1 Microgen Details

2.13.2 Microgen Major Business

2.13.3 Microgen Tuberculosis Prevention and Treatment Vaccine Product and Services

2.13.4 Microgen Tuberculosis Prevention and Treatment Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

3 Tuberculosis Prevention and Treatment Vaccine Sales by Manufacturer

3.1 Global Tuberculosis Prevention and Treatment Vaccine Sales in Volume by Manufacturer (2019-2021e)

3.2 Global Tuberculosis Prevention and Treatment Vaccine Revenue by Manufacturer (2019-2021e)

3.3 Key Manufacturer Market Position in Tuberculosis Prevention and Treatment Vaccine

3.4 Market Concentration Rate

3.4.1 Top 3 Tuberculosis Prevention and Treatment Vaccine Manufacturer Market Share

3.4.2 Top 6 Tuberculosis Prevention and Treatment Vaccine Manufacturer Market Share

3.5 Global Tuberculosis Prevention and Treatment Vaccine Production Capacity by Company

3.6 Manufacturer by Geography: Head Office and Tuberculosis Prevention and Treatment Vaccine Production Site

3.7 New Entrant and Capacity Expansion Plans

3.8 Mergers & Acquisitions

4 Market Analysis by Region

4.1 Global Tuberculosis Prevention and Treatment Vaccine Market Size by Region

4.1.1 Global Tuberculosis Prevention and Treatment Vaccine Sales in Volume by Region (2016-2026)

4.1.2 Global Tuberculosis Prevention and Treatment Vaccine Revenue by Region (2016-2026)

4.2 North America Tuberculosis Prevention and Treatment Vaccine Revenue (2016-2026)

4.3 Europe Tuberculosis Prevention and Treatment Vaccine Revenue (2016-2026)

4.4 Asia-Pacific Tuberculosis Prevention and Treatment Vaccine Revenue (2016-2026)

4.5 South America Tuberculosis Prevention and Treatment Vaccine Revenue (2016-2026)

4.6 Middle East and Africa Tuberculosis Prevention and Treatment Vaccine Revenue (2016-2026)

5 Market Segment by Type

5.1 Global Tuberculosis Prevention and Treatment Vaccine Sales in Volume by Type (2016-2026)

5.2 Global Tuberculosis Prevention and Treatment Vaccine Revenue by Type (2016-2026)

5.3 Global Tuberculosis Prevention and Treatment Vaccine Price by Type (2016-2026)

6 Market Segment by Application

6.1 Global Tuberculosis Prevention and Treatment Vaccine Sales in Volume by Application (2016-2026)

6.2 Global Tuberculosis Prevention and Treatment Vaccine Revenue by Application (2016-2026)

6.3 Global Tuberculosis Prevention and Treatment Vaccine Price by Application (2016-2026)

7 North America by Country, by Type, and by Application

7.1 North America Tuberculosis Prevention and Treatment Vaccine Sales by Type (2016-2026)

7.2 North America Tuberculosis Prevention and Treatment Vaccine Sales by Application (2016-2026)

7.3 North America Tuberculosis Prevention and Treatment Vaccine Market Size by Country

7.3.1 North America Tuberculosis Prevention and Treatment Vaccine Sales in Volume by Country (2016-2026)

7.3.2 North America Tuberculosis Prevention and Treatment Vaccine Revenue by Country (2016-2026)

7.3.3 United States Market Size and Forecast (2016-2026)

7.3.4 Canada Market Size and Forecast (2016-2026)

7.3.5 Mexico Market Size and Forecast (2016-2026)

8 Europe by Country, by Type, and by Application

8.1 Europe Tuberculosis Prevention and Treatment Vaccine Sales by Type (2016-2026)

8.2 Europe Tuberculosis Prevention and Treatment Vaccine Sales by Application (2016-2026)

8.3 Europe Tuberculosis Prevention and Treatment Vaccine Market Size by Country

8.3.1 Europe Tuberculosis Prevention and Treatment Vaccine Sales in Volume by Country (2016-2026)

8.3.2 Europe Tuberculosis Prevention and Treatment Vaccine Revenue by Country (2016-2026)

8.3.3 Germany Market Size and Forecast (2016-2026)

8.3.4 France Market Size and Forecast (2016-2026)

8.3.5 United Kingdom Market Size and Forecast (2016-2026)

8.3.6 Russia Market Size and Forecast (2016-2026)

8.3.7 Italy Market Size and Forecast (2016-2026)

9 Asia-Pacific by Country, by Type, and by Application

9.1 Asia-Pacific Tuberculosis Prevention and Treatment Vaccine Sales by Type (2016-2026)

9.2 Asia-Pacific Tuberculosis Prevention and Treatment Vaccine Sales by Application (2016-2026)

9.3 Asia-Pacific Tuberculosis Prevention and Treatment Vaccine Market Size by Region

9.3.1 Asia-Pacific Tuberculosis Prevention and Treatment Vaccine Sales in Volume by Region (2016-2026)

9.3.2 Asia-Pacific Tuberculosis Prevention and Treatment Vaccine Revenue by Region (2016-2026)

9.3.3 China Market Size and Forecast (2016-2026)

9.3.4 Japan Market Size and Forecast (2016-2026)

9.3.5 Korea Market Size and Forecast (2016-2026)

9.3.6 India Market Size and Forecast (2016-2026)

9.3.7 Southeast Asia Market Size and Forecast (2016-2026)

9.3.8 Australia Market Size and Forecast (2016-2026)

10 South America by Country, by Type, and by Application

10.1 South America Tuberculosis Prevention and Treatment Vaccine Sales by Type (2016-2026)

10.2 South America Tuberculosis Prevention and Treatment Vaccine Sales by Application (2016-2026)

10.3 South America Tuberculosis Prevention and Treatment Vaccine Market Size by Country

10.3.1 South America Tuberculosis Prevention and Treatment Vaccine Sales in Volume by Country (2016-2026)

10.3.2 South America Tuberculosis Prevention and Treatment Vaccine Revenue by Country (2016-2026)

10.3.3 Brazil Market Size and Forecast (2016-2026)

10.3.4 Argentina Market Size and Forecast (2016-2026)

11 Middle East & Africa by Country, by Type, and by Application

11.1 Middle East & Africa Tuberculosis Prevention and Treatment Vaccine Sales by Type (2016-2026)

11.2 Middle East & Africa Tuberculosis Prevention and Treatment Vaccine Sales by Application (2016-2026)

11.3 Middle East & Africa Tuberculosis Prevention and Treatment Vaccine Market Size by Country

11.3.1 Middle East & Africa Tuberculosis Prevention and Treatment Vaccine Sales in Volume by Country (2016-2026)

11.3.2 Middle East & Africa Tuberculosis Prevention and Treatment Vaccine Revenue by Country (2016-2026)

11.3.3 Turkey Market Size and Forecast (2016-2026)

11.3.4 Egypt Market Size and Forecast (2016-2026)

11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)

11.3.6 South Africa Market Size and Forecast (2016-2026)

12 Sales Channel, Distributors, Traders and Dealers

12.1 Sales Channel

12.1.1 Direct Marketing

12.1.2 Indirect Marketing

12.2 Tuberculosis Prevention and Treatment Vaccine Typical Distributors

12.3 Tuberculosis Prevention and Treatment Vaccine Typical Customers

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Research Process and Data Source

14.3 Disclaimer

List of Tables

Table 1. Global Tuberculosis Prevention and Treatment Vaccine Revenue by Type, (USD Million), 2021-2026

Table 2. Global Tuberculosis Prevention and Treatment Vaccine Revenue by Application, (USD Million), 2021-2026

Table 3. Merck Basic Information, Manufacturing Base and Competitors

Table 4. Merck Major Business

Table 5. Merck Tuberculosis Prevention and Treatment Vaccine Product and Services

Table 6. Merck Tuberculosis Prevention and Treatment Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 7. Japan BCG Lab Basic Information, Manufacturing Base and Competitors

Table 8. Japan BCG Lab Major Business

Table 9. Japan BCG Lab Tuberculosis Prevention and Treatment Vaccine Product and Services

Table 10. Japan BCG Lab Tuberculosis Prevention and Treatment Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 11. Serum Institute of India Basic Information, Manufacturing Base and Competitors

Table 12. Serum Institute of India Major Business

Table 13. Serum Institute of India Tuberculosis Prevention and Treatment Vaccine Product and Services

Table 14. Serum Institute of India Tuberculosis Prevention and Treatment Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 15. AJ Vaccines Basic Information, Manufacturing Base and Competitors

Table 16. AJ Vaccines Major Business

Table 17. AJ Vaccines Tuberculosis Prevention and Treatment Vaccine Product and Services

Table 18. AJ Vaccines Tuberculosis Prevention and Treatment Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 19. BioFarma Basic Information, Manufacturing Base and Competitors

Table 20. BioFarma Major Business

Table 21. BioFarma Tuberculosis Prevention and Treatment Vaccine Product and Services

Table 22. BioFarma Tuberculosis Prevention and Treatment Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 23. GreenSignal Bio Pharma Basic Information, Manufacturing Base and Competitors

Table 24. GreenSignal Bio Pharma Major Business

Table 25. GreenSignal Bio Pharma Tuberculosis Prevention and Treatment Vaccine Product and Services

Table 26. GreenSignal Bio Pharma Tuberculosis Prevention and Treatment Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 27. China National Biotec Basic Information, Manufacturing Base and Competitors

Table 28. China National Biotec Major Business

Table 29. China National Biotec Tuberculosis Prevention and Treatment Vaccine Product and Services

Table 30. China National Biotec Tuberculosis Prevention and Treatment Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 31. Biomed Lublin Basic Information, Manufacturing Base and Competitors

Table 32. Biomed Lublin Major Business

Table 33. Biomed Lublin Tuberculosis Prevention and Treatment Vaccine Product and Services

Table 34. Biomed Lublin Tuberculosis Prevention and Treatment Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 35. Taj Pharmaceuticals Basic Information, Manufacturing Base and Competitors

Table 36. Taj Pharmaceuticals Major Business

Table 37. Taj Pharmaceuticals Tuberculosis Prevention and Treatment Vaccine Product and Services

Table 38. Taj Pharmaceuticals Tuberculosis Prevention and Treatment Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 39. Ataulpho de Paiva Basic Information, Manufacturing Base and Competitors

Table 40. Ataulpho de Paiva Major Business

Table 41. Ataulpho de Paiva Tuberculosis Prevention and Treatment Vaccine Product and Services

Table 42. Ataulpho de Paiva Tuberculosis Prevention and Treatment Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 43. IVAC Basic Information, Manufacturing Base and Competitors

Table 44. IVAC Major Business

Table 45. IVAC Tuberculosis Prevention and Treatment Vaccine Product and Services

Table 46. IVAC Tuberculosis Prevention and Treatment Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 47. Queen Saovabha Mem. Inst Basic Information, Manufacturing Base and Competitors

Table 48. Queen Saovabha Mem. Inst Major Business

Table 49. Queen Saovabha Mem. Inst Tuberculosis Prevention and Treatment Vaccine Product and Services

Table 50. Queen Saovabha Mem. Inst Tuberculosis Prevention and Treatment Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 51. Microgen Basic Information, Manufacturing Base and Competitors

Table 52. Microgen Major Business

Table 53. Microgen Tuberculosis Prevention and Treatment Vaccine Product and Services

Table 54. Microgen Tuberculosis Prevention and Treatment Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 55. Global Tuberculosis Prevention and Treatment Vaccine Sales by Manufacturer (2019-2021e) & (K Units)

Table 56. Global Tuberculosis Prevention and Treatment Vaccine Revenue by Manufacturer (2019-2021e) & (USD Million)

Table 57. Market Position of Manufacturers in Tuberculosis Prevention and Treatment Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020

Table 58. Global Tuberculosis Prevention and Treatment Vaccine Production Capacity by Company, (K Units): 2020 VS 2021

Table 59. Head Office and Tuberculosis Prevention and Treatment Vaccine Production Site of Key Manufacturer

Table 60. Tuberculosis Prevention and Treatment Vaccine New Entrant and Capacity Expansion Plans

Table 61. Tuberculosis Prevention and Treatment Vaccine Mergers & Acquisitions in the Past Five Years

Table 62. Global Tuberculosis Prevention and Treatment Vaccine Sales by Region (2016-2021e) & (K Units)

Table 63. Global Tuberculosis Prevention and Treatment Vaccine Sales by Region (2021-2026) & (K Units)

Table 64. Global Tuberculosis Prevention and Treatment Vaccine Revenue by Region (2016-2021e) & (USD Million)

Table 65. Global Tuberculosis Prevention and Treatment Vaccine Revenue by Region (2021-2026) & (USD Million)

Table 66. Global Tuberculosis Prevention and Treatment Vaccine Sales by Type (2016-2021e) & (K Units)

Table 67. Global Tuberculosis Prevention and Treatment Vaccine Sales by Type (2021-2026) & (K Units)

Table 68. Global Tuberculosis Prevention and Treatment Vaccine Revenue by Type (2016-2021e) & (USD Million)

Table 69. Global Tuberculosis Prevention and Treatment Vaccine Revenue by Type (2021-2026) & (USD Million)

Table 70. Global Tuberculosis Prevention and Treatment Vaccine Price by Type (2016-2021e) & (US$/Unit)

Table 71. Global Tuberculosis Prevention and Treatment Vaccine Price by Type (2021-2026) & (US$/Unit)

Table 72. Global Tuberculosis Prevention and Treatment Vaccine Sales by Application (2016-2021e) & (K Units)

Table 73. Global Tuberculosis Prevention and Treatment Vaccine Sales by Application (2021-2026) & (K Units)

Table 74. Global Tuberculosis Prevention and Treatment Vaccine Revenue by Application (2016-2021e) & (USD Million)

Table 75. Global Tuberculosis Prevention and Treatment Vaccine Revenue by Application (2021-2026) & (USD Million)

Table 76. Global Tuberculosis Prevention and Treatment Vaccine Price by Application (2016-2021e) & (US$/Unit)

Table 77. Global Tuberculosis Prevention and Treatment Vaccine Price by Application (2021-2026) & (US$/Unit)

Table 78. North America Tuberculosis Prevention and Treatment Vaccine Sales by Country (2016-2021e) & (K Units)

Table 79. North America Tuberculosis Prevention and Treatment Vaccine Sales by Country (2021-2026) & (K Units)

Table 80. North America Tuberculosis Prevention and Treatment Vaccine Revenue by Country (2016-2021e) & (USD Million)

Table 81. North America Tuberculosis Prevention and Treatment Vaccine Revenue by Country (2021-2026) & (USD Million)

Table 82. North America Tuberculosis Prevention and Treatment Vaccine Sales by Type (2016-2021e) & (K Units)

Table 83. North America Tuberculosis Prevention and Treatment Vaccine Sales by Type (2021-2026) & (K Units)

Table 84. North America Tuberculosis Prevention and Treatment Vaccine Sales by Application (2016-2021e) & (K Units)

Table 85. North America Tuberculosis Prevention and Treatment Vaccine Sales by Application (2021-2026) & (K Units)

Table 86. Europe Tuberculosis Prevention and Treatment Vaccine Sales by Country (2016-2021e) & (K Units)

Table 87. Europe Tuberculosis Prevention and Treatment Vaccine Sales by Country (2021-2026) & (K Units)

Table 88. Europe Tuberculosis Prevention and Treatment Vaccine Revenue by Country (2016-2021e) & (USD Million)

Table 89. Europe Tuberculosis Prevention and Treatment Vaccine Revenue by Country (2021-2026) & (USD Million)

Table 90. Europe Tuberculosis Prevention and Treatment Vaccine Sales by Type (2016-2021e) & (K Units)

Table 91. Europe Tuberculosis Prevention and Treatment Vaccine Sales by Type (2021-2026) & (K Units)

Table 92. Europe Tuberculosis Prevention and Treatment Vaccine Sales by Application (2016-2021e) & (K Units)

Table 93. Europe Tuberculosis Prevention and Treatment Vaccine Sales by Application (2021-2026) & (K Units)

Table 94. Asia-Pacific Tuberculosis Prevention and Treatment Vaccine Sales by Region (2016-2021e) & (K Units)

Table 95. Asia-Pacific Tuberculosis Prevention and Treatment Vaccine Sales by Region (2021-2026) & (K Units)

Table 96. Asia-Pacific Tuberculosis Prevention and Treatment Vaccine Revenue by Region (2016-2021e) & (USD Million)

Table 97. Asia-Pacific Tuberculosis Prevention and Treatment Vaccine Revenue by Region (2021-2026) & (USD Million)

Table 98. Asia-Pacific Tuberculosis Prevention and Treatment Vaccine Sales by Type (2016-2021e) & (K Units)

Table 99. Asia-Pacific Tuberculosis Prevention and Treatment Vaccine Sales by Type (2021-2026) & (K Units)

Table 100. Asia-Pacific Tuberculosis Prevention and Treatment Vaccine Sales by Application (2016-2021e) & (K Units)

Table 101. Asia-Pacific Tuberculosis Prevention and Treatment Vaccine Sales by Application (2021-2026) & (K Units)

Table 102. South America Tuberculosis Prevention and Treatment Vaccine Sales by Country (2016-2021e) & (K Units)

Table 103. South America Tuberculosis Prevention and Treatment Vaccine Sales by Country (2021-2026) & (K Units)

Table 104. South America Tuberculosis Prevention and Treatment Vaccine Revenue by Country (2016-2021e) & (USD Million)

Table 105. South America Tuberculosis Prevention and Treatment Vaccine Revenue by Country (2021-2026) & (USD Million)

Table 106. South America Tuberculosis Prevention and Treatment Vaccine Sales by Type (2016-2021e) & (K Units)

Table 107. South America Tuberculosis Prevention and Treatment Vaccine Sales by Type (2021-2026) & (K Units)

Table 108. South America Tuberculosis Prevention and Treatment Vaccine Sales by Application (2016-2021e) & (K Units)

Table 109. South America Tuberculosis Prevention and Treatment Vaccine Sales by Application (2021-2026) & (K Units)

Table 110. Middle East & Africa Tuberculosis Prevention and Treatment Vaccine Sales by Country (2016-2021e) & (K Units)

Table 111. Middle East & Africa Tuberculosis Prevention and Treatment Vaccine Sales by Country (2021-2026) & (K Units)

Table 112. Middle East & Africa Tuberculosis Prevention and Treatment Vaccine Revenue by Country (2016-2021e) & (USD Million)

Table 113. Middle East & Africa Tuberculosis Prevention and Treatment Vaccine Revenue by Country (2021-2026) & (USD Million)

Table 114. Middle East & Africa Tuberculosis Prevention and Treatment Vaccine Sales by Type (2016-2021e) & (K Units)

Table 115. Middle East & Africa Tuberculosis Prevention and Treatment Vaccine Sales by Type (2021-2026) & (K Units)

Table 116. Middle East & Africa Tuberculosis Prevention and Treatment Vaccine Sales by Application (2016-2021e) & (K Units)

Table 117. Middle East & Africa Tuberculosis Prevention and Treatment Vaccine Sales by Application (2021-2026) & (K Units)

Table 118. Direct Channel Pros & Cons

Table 119. Indirect Channel Pros & Cons

Table 120. Tuberculosis Prevention and Treatment Vaccine Typical Distributors

Table 121. Tuberculosis Prevention and Treatment Vaccine Typical Customers

List of Figures

Figure 1. Tuberculosis Prevention and Treatment Vaccine Picture

Figure 2. Global Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Type in 2020

Figure 3. Immune Vaccine

Figure 4. Therapy Vaccine

Figure 5. Global Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Application in 2020

Figure 6. Self-Procurement

Figure 7. UNICEF

Figure 8. Other

Figure 9. Global Tuberculosis Prevention and Treatment Vaccine Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026

Figure 10. Global Tuberculosis Prevention and Treatment Vaccine Market Size and Forecast (2016-2026) & (USD Million)

Figure 11. Global Tuberculosis Prevention and Treatment Vaccine Sales (2016-2026) & (K Units)

Figure 12. Global Tuberculosis Prevention and Treatment Vaccine Price by Type (2016-2026) & (US$/Unit)

Figure 13. Global Tuberculosis Prevention and Treatment Vaccine Production Capacity (2016-2026) & (K Units)

Figure 14. Global Tuberculosis Prevention and Treatment Vaccine Production Capacity by Geographic Region: 2020 VS 2021

Figure 15. Tuberculosis Prevention and Treatment Vaccine Market Drivers

Figure 16. Tuberculosis Prevention and Treatment Vaccine Market Restraints

Figure 17. Tuberculosis Prevention and Treatment Vaccine Market Trends

Figure 18. Global Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Manufacturer in 2020

Figure 19. Global Tuberculosis Prevention and Treatment Vaccine Revenue Market Share by Manufacturer in 2020

Figure 20. Tuberculosis Prevention and Treatment Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 21. Top 3 Tuberculosis Prevention and Treatment Vaccine Manufacturer (Revenue) Market Share in 2020

Figure 22. Top 6 Tuberculosis Prevention and Treatment Vaccine Manufacturer (Revenue) Market Share in 2020

Figure 23. Global Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Region (2016-2026)

Figure 24. Global Tuberculosis Prevention and Treatment Vaccine Revenue Market Share by Region (2016-2026)

Figure 25. North America Tuberculosis Prevention and Treatment Vaccine Revenue (2016-2026) & (USD Million)

Figure 26. Europe Tuberculosis Prevention and Treatment Vaccine Revenue (2016-2026) & (USD Million)

Figure 27. Asia-Pacific Tuberculosis Prevention and Treatment Vaccine Revenue (2016-2026) & (USD Million)

Figure 28. South America Tuberculosis Prevention and Treatment Vaccine Revenue (2016-2026) & (USD Million)

Figure 29. Middle East & Africa Tuberculosis Prevention and Treatment Vaccine Revenue (2016-2026) & (USD Million)

Figure 30. Global Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Type (2016-2026)

Figure 31. Global Tuberculosis Prevention and Treatment Vaccine Revenue Market Share by Type (2016-2026)

Figure 32. Global Tuberculosis Prevention and Treatment Vaccine Price by Type (2016-2026) & (US$/Unit)

Figure 33. Global Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Application (2016-2026)

Figure 34. Global Tuberculosis Prevention and Treatment Vaccine Revenue Market Share by Application (2016-2026)

Figure 35. Global Tuberculosis Prevention and Treatment Vaccine Price by Application (2016-2026) & (US$/Unit)

Figure 36. North America Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Type (2016-2026)

Figure 37. North America Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Application (2016-2026)

Figure 38. North America Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Country (2016-2026)

Figure 39. North America Tuberculosis Prevention and Treatment Vaccine Revenue Market Share by Country (2016-2026)

Figure 40. United States Tuberculosis Prevention and Treatment Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 41. Canada Tuberculosis Prevention and Treatment Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 42. Mexico Tuberculosis Prevention and Treatment Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 43. Europe Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Type (2016-2026)

Figure 44. Europe Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Application (2016-2026)

Figure 45. Europe Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Country (2016-2026)

Figure 46. Europe Tuberculosis Prevention and Treatment Vaccine Revenue Market Share by Country (2016-2026)

Figure 47. Germany Tuberculosis Prevention and Treatment Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 48. France Tuberculosis Prevention and Treatment Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 49. United Kingdom Tuberculosis Prevention and Treatment Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 50. Russia Tuberculosis Prevention and Treatment Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 51. Italy Tuberculosis Prevention and Treatment Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 52. Asia-Pacific Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Region (2016-2026)

Figure 53. Asia-Pacific Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Application (2016-2026)

Figure 54. Asia-Pacific Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Region (2016-2026)

Figure 55. Asia-Pacific Tuberculosis Prevention and Treatment Vaccine Revenue Market Share by Region (2016-2026)

Figure 56. China Tuberculosis Prevention and Treatment Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 57. Japan Tuberculosis Prevention and Treatment Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 58. Korea Tuberculosis Prevention and Treatment Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 59. India Tuberculosis Prevention and Treatment Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 60. Southeast Asia Tuberculosis Prevention and Treatment Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 61. Australia Tuberculosis Prevention and Treatment Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 62. South America Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Type (2016-2026)

Figure 63. South America Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Application (2016-2026)

Figure 64. South America Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Country (2016-2026)

Figure 65. South America Tuberculosis Prevention and Treatment Vaccine Revenue Market Share by Country (2016-2026)

Figure 66. Brazil Tuberculosis Prevention and Treatment Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 67. Argentina Tuberculosis Prevention and Treatment Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 68. Middle East & Africa Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Type (2016-2026)

Figure 69. Middle East & Africa Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Application (2016-2026)

Figure 70. Middle East & Africa Tuberculosis Prevention and Treatment Vaccine Sales Market Share by Country (2016-2026)

Figure 71. Middle East & Africa Tuberculosis Prevention and Treatment Vaccine Revenue Market Share by Country (2016-2026)

Figure 72. Turkey Tuberculosis Prevention and Treatment Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 73. Egypt Tuberculosis Prevention and Treatment Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 74. Saudi Arabia Tuberculosis Prevention and Treatment Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 75. South Africa Tuberculosis Prevention and Treatment Vaccine Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 76. Sales Channel: Direct Channel vs Indirect Channel

Figure 77. Methodology

Figure 78. Research Process and Data Source